The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Browse all articles A–Z →
Methotrexate Shortage: What Providers and Prescribers Need to Know in 2026
The methotrexate injection shortage persists in 2026. Here is what rheumatologists, oncologists, and PCPs need to know about availability and alternatives.

Minastrin 24 Fe Shortage: What Providers and Prescribers Need to Know in 2026
Minastrin 24 Fe has been discontinued. This provider-focused guide covers therapeutic substitutions, flexible prescribing practices, patient counseling points, and formulary considerations for 2026.

Mirabegron XR Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for urologists, PCPs, and urogynecologists on Mirabegron XR supply disruptions, insurance changes, and how to manage patient access in 2026.

Motpoly XR Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for neurologists, epileptologists, and prescribers on Motpoly XR access challenges in 2026 — including insurance hurdles, bridging strategies, and patient support resources.
48,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.

Mycophenolate Mofetil Shortage: What Providers and Prescribers Need to Know in 2026
The mycophenolate mofetil shortage creates real clinical challenges for transplant teams and rheumatologists. Here's what prescribers need to know and do in 2026.

Nextstellis 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for OB/GYNs, PCPs, and NPs on Nextstellis availability challenges in 2026, including prescribing workarounds, alternatives, and patient communication strategies.

Nivestym Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for oncologists and prescribers on Nivestym (filgrastim-aafi) availability challenges in 2026, including biosimilar alternatives, formulary navigation, and patient support resources.

Norgestrel Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview for OB/GYNs, PCPs, and NPs: norgestrel (Opill) availability in 2026, patient access barriers, and prescribing alternatives when needed.

Nuedexta Shortage: What Providers and Prescribers Need to Know in 2026
While Nuedexta is not on the FDA shortage list, prescribers are seeing real access barriers. Here's what providers need to know about availability, PA, and patient support in 2026.

Spinraza (Nusinersen) Access Update: What Providers and Prescribers Need to Know in 2026
The FDA approved a high-dose Spinraza regimen in March 2026, new gene therapies have entered the market, and insurer policies are evolving. Here's what SMA prescribers need to know.

Ogsiveo Shortage: What Providers and Prescribers Need to Know in 2026
Ogsiveo is not in FDA shortage, but access issues, prior auth burdens, and the 2025 tablet change are causing real disruptions. Key facts for prescribers.

Pentoxifylline XR Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on Pentoxifylline XR availability in 2026: supply factors, evidence-based alternatives, patient communication strategies, and prescribing resources.